Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Dopamine (DA) is a key neurotransmitter regulating motor control, motivation, and endocrine functions.
• DA system dysregulation is implicated in Parkinson's disease, schizophrenia, and addiction.
• The complexity of the DA system hinders understanding of its pathological mechanisms.

Purpose of the Study:

• To review the application of chemogenetics in studying the dopamine system.
• To highlight how chemogenetics has advanced the understanding of DA signaling and behavior.
• To discuss the challenges and potential of chemogenetic tools in neuroscience research.

Main Methods:

• Utilizing Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) for targeted neuronal control.
• Employing chemogenetics to achieve pharmacological remote control of neuronal activity.
• Reviewing recent studies that applied chemogenetics to the dopamine system.

Main Results:

• Chemogenetics has significantly advanced the functional study of the DA system.
• This technique provides novel insights into DA signaling pathways and associated behaviors.
• Identified challenges include ligand metabolism, such as clozapine N-oxide (CNO) conversion to clozapine.

Conclusions:

• Chemogenetics is an exceptional tool for studying neuronal function, particularly within the DA system.
• Despite challenges, the chemogenetic toolbox holds immense potential for future research.
• Continued refinement of chemogenetic techniques will further elucidate DA signaling mechanisms in health and disease.